China's Top Departments: Oncology at Guangdong Provincial People's Hospital

If you or a family member is facing lung cancer or another solid tumor that needs a precise molecular workup, a second opinion on a complex case, or multidisciplinary treatment planning, the Cancer Center of Guangdong Provincial People's Hospital — also known as the Guangdong Provincial People's Hospital Cancer Hospital — is one of South China's leading destinations. Built on the Guangdong Lung Cancer Institute (GLCI), where Prof. Wu Yilong's team leads the landmark CTONG trial series, the center delivers lung-cancer precision care from AI-based early screening to VATS minimally invasive surgery and targeted therapy, alongside multidisciplinary team (MDT) care across major tumor types. For cross-border patients, the hospital's Concord Senior Medical Center provides one-stop, full-journey international care.

About the Hospital

Guangdong Provincial People's Hospital (also known as the Guangdong Academy of Medical Sciences) is a large modern Grade A tertiary (Sanjia) general hospital in China, founded in 1946 (originally Guangzhou Central Hospital). In China's National Tertiary Public Hospital Performance Assessment it has been rated A++, the top tier, within the national top 1%.

• Tier: Grade A tertiary general hospital; national performance assessment A++ (top 1% nationwide)
• Academic strength: 6 major research and medical centers, 18 National Key Clinical Specialties and 36 Guangdong Provincial Key Clinical Specialties
• Affiliated institutes: Includes six directly affiliated institutions — the Guangdong Provincial Institute of Cardiovascular Diseases, the Guangdong Provincial Institute of Geriatrics, the Guangdong Lung Cancer Institute and the Guangdong Provincial Institute of Eye Disease Prevention and Treatment; in 2009 the hospital was additionally designated the Guangdong Academy of Medical Sciences
• Address: No. 106 Zhongshan Er Road, Yuexiu District, Guangzhou, Guangdong (downtown)
• Transport: Located in downtown Yuexiu District with convenient public transport; Guangzhou is the core city of the Guangdong–Hong Kong–Macao Greater Bay Area. Baiyun International Airport serves international and Southeast Asian routes, and the Guangzhou–Shenzhen–Hong Kong High-Speed Rail connects to Hong Kong West Kowloon, making access easy for patients from Hong Kong, Macao, Taiwan and overseas
• International services: The Concord Senior Medical Center (located in the East Ward, established in 1996) is the first international medical platform in a Chinese public hospital to adopt the operating model of a Hong Kong private hospital. It serves international patients, compatriots from Hong Kong/Macao/Taiwan, expatriates and premium insured clients with one-stop, full-journey international care

About the Department

The Cancer Center of Guangdong Provincial People's Hospital comprises the hospital's oncology specialty system, also known externally as the Guangdong Provincial People's Hospital Cancer Hospital. Supported by the Guangdong Lung Cancer Institute (GLCI) — one of the hospital's six directly affiliated institutions — it forms a comprehensive cancer diagnosis-and-treatment platform with lung cancer precision care as its standout feature, covering multiple tumor types.

• Leadership: Public reports indicate that Prof. Zhou Qing serves as President of the Guangdong Provincial People's Hospital Cancer Hospital, with Prof. Zhong Wenzhao as Vice President
• Guangdong Lung Cancer Institute (GLCI): Prof. Wu Yilong is Honorary Director, Prof. Zhou Qing is Deputy Director and Prof. Zhong Wenzhao is Director; it is one of China's earlier institutes dedicated to lung cancer research
• Department of Medical Oncology: Established in 2004 as a secondary clinical department with 45 beds; it focuses on gastrointestinal tumors, head and neck tumors, and urological and gynecological tumors, and provides early screening, diagnosis and multidisciplinary treatment
• Department of Breast Surgery: Led by Prof. Liao Ning, it focuses on individualized precision treatment of breast cancer and long runs the "Prof. Liao Ning International Consultation" multidisciplinary breast cancer case conference
• Tumor types covered: thoracic tumors (lung cancer, etc.), gastrointestinal tumors, head and neck tumors, breast tumors, and urological and gynecological tumors

Academic Standing and Accreditation

• Oncology: Ranked 3rd in South China in the Fudan edition of the "2021 Regional Specialty Reputation Rankings for Oncology in South China"
• The hospital overall: In the Fudan edition of the "2022 China Hospital Specialty Reputation Rankings", the hospital's radiology, cardiovascular medicine, cardiac surgery and geriatrics entered the national top 10 for their specialties
• Guangdong Lung Cancer Institute: Has long led the Chinese Thoracic Oncology Group (CTONG) clinical trial series, an important academic platform for thoracic oncology research in China
• The hospital organizes cancer care around multidisciplinary team (MDT) treatment, offering one-stop care for patients with complex tumors

Core Technologies / Signature Conditions

1. Lung cancer precision diagnosis and treatment
   • Molecular profiling of lung cancer (driver genes such as EGFR and ALK) with targeted therapy, immunotherapy and perioperative precision treatment
   • Prof. Wu Yilong's team has long led international and domestic multicenter clinical trials (the CTONG series) and pioneered the "patient-centric clinical trial" design (e.g. a real-world study of an EGFR-positive non-small cell lung cancer with brain metastases)
2. Lung cancer early screening and minimally invasive surgery
   • Prof. Zhong Wenzhao's team developed an AI imaging–liquid biopsy lung cancer early-screening and triage system
   • Performs video-assisted thoracoscopic (VATS) minimally invasive radical lung cancer surgery, supported by a preoperative planning system based on 3D reconstruction–fluorescence imaging watershed analysis
   • Led the establishment of a Stage III lung cancer multidisciplinary joint clinic, providing one-stop, individualized diagnosis–treatment–follow-up for complex and difficult lung cancer cases
3. Multidisciplinary team (MDT) cancer treatment
   • The Department of Medical Oncology manages gastrointestinal tumors, head and neck tumors, and urological and gynecological tumors through multidisciplinary collaboration, with individualized precision treatment
4. Individualized precision treatment of breast cancer
   • The Department of Breast Surgery focuses on breast cancer staging, sentinel lymph node assessment, molecular classification and precision treatment, and connects with international experts such as those at MD Anderson through the "Prof. Liao Ning International Consultation"
5. Thoracic tumor surgery
   • The Department of Thoracic Surgery is a major referral center for complex chest diseases (lung, esophagus, thymus, mediastinum and chest wall) in South China, performing lung transplantation, sleeve lobectomy, esophagectomy and thymectomy

Expert Team

• Prof. Wu Yilong: Professor of Oncology, doctoral supervisor; recipient of the IASLC Distinguished Scientific Award (International Association for the Study of Lung Cancer); Vice President of the Chinese Medical Doctor Association (CMDA); President of the Guangdong Medical Doctor Association; Chief Expert of Guangdong Provincial People's Hospital; Honorary Director of the Guangdong Lung Cancer Institute; Chairman of the Chinese Thoracic Oncology Group (CTONG); a Clarivate Highly Cited Researcher in clinical medicine for 2018–2024
• Prof. Zhou Qing: President of the Guangdong Provincial People's Hospital Cancer Hospital; Deputy Director of the Guangdong Lung Cancer Institute; Changjiang Scholar Distinguished Professor of the Ministry of Education; member of the IASLC Career Development and Fellowships Committee; Vice Chair and Secretary-General of CTONG
• Prof. Zhong Wenzhao: Chief Physician, Department of Lung Surgery; Director of the Guangdong Lung Cancer Institute; Vice President of the Guangdong Provincial People's Hospital Cancer Hospital; doctoral supervisor; Guangdong Outstanding Young Medical Talent; Associate Editor of J Thorac Oncol, the official journal of the IASLC; received the 2020 Guangdong Provincial Science and Technology Progress Award (First Prize) as first contributor
• Prof. Liao Ning: Director of the Department of Breast Surgery, doctoral supervisor; Standing Committee Member of the Breast Cancer Committee of the Chinese Anti-Cancer Association; member of the International Council of the Society of Surgical Oncology (SSO); member of the International Council of the International Sentinel Node Society (ISNS)
• Note: The titles/positions above are based on public sources; please refer to the hospital's latest official information for current departmental leadership

Suitable Conditions (for international patients)

• Lung cancer: early-stage pulmonary nodules, EGFR/ALK driver-gene positive disease, brain metastases, complex Stage III cases
• Breast cancer: staging, sentinel lymph node assessment, molecular classification and individualized treatment
• Gastrointestinal tumors: stomach, colorectal, hepatobiliary and pancreatic
• Head and neck tumors
• Urological and gynecological tumors
• Thoracic tumors: esophageal, thymic and mediastinal
• Patients with complex tumors requiring multidisciplinary team (MDT) treatment / international case consultation

Address and Contact

• Address: No. 106 Zhongshan Er Road, Yuexiu District, Guangzhou, Guangdong
• Main switchboard: (020) 83827812; Fax: 020-83827712
• Website: www.gdghospital.org.cn (English: www.gdghospital.org.cn/en)
• International medical platform: Concord Senior Medical Center (East Ward, established 1996)

For a quick overview of the department, see the Guangdong Provincial People's Hospital Cancer Center department page.

Navigating a cancer diagnosis? Contact Medora for a free, personalized consultation. We'll review your condition, connect you with the right subspecialty team, and coordinate your entire journey — from medical record translation to treatment and follow-up.